Yuanyuan Liu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Immune Response

Top Venues

Molecular pharmaceutics

Journal of materials chemistry. B

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Tao Zhang, Liya Bai, Ran You, Meng Yang, Qian Chen, Yuanyuan Cheng, Zhanyin Qian, Yinsong Wang, Yuanyuan Liu
Homologous-targeting biomimetic nanoparticles co-loaded with melittin and a photosensitizer for the combination therapy of triple negative breast cancer. Journal of materials chemistry. B 12 (22) (2024)
Tao Zhang, Liya Bai, Ran You, Meng Yang, Qian Chen, Yuanyuan Cheng, Zhanyin Qian, Yinsong Wang, Yuanyuan Liu
Homologous-targeting biomimetic nanoparticles co-loaded with melittin and a photosensitizer for the combination therapy of triple negative breast cancer. Journal of materials chemistry. B (2024)
Liya Bai, Hui Liu, Ran You, Xiaoyu Jiang, Tao Zhang, Yunan Li, Tianhe Shan, Zhanyin Qian, Yinsong Wang, Yuanyuan Liu, Chunyu Li
Combination Nano-Delivery Systems Remodel the Immunosuppressive Tumor Microenvironment for Metastatic Triple-Negative Breast Cancer Therapy. Molecular pharmaceutics (2024)
Liya Bai, Hui Liu, Ran You, Xiaoyu Jiang, Tao Zhang, Yunan Li, Tianhe Shan, Zhanyin Qian, Yinsong Wang, Yuanyuan Liu, Chunyu Li
Combination Nano-Delivery Systems Remodel the Immunosuppressive Tumor Microenvironment for Metastatic Triple-Negative Breast Cancer Therapy. Molecular pharmaceutics 21 (5) (2024)
Yun Liu, Fang Cao, Fantong Xia, Jie Li, Xiaobao Dong, Yan Guo, Jun Zhang, Qiang Zhao, Yuanyuan Liu
Shc3 facilitates breast cancer drug resistance by interacting with ErbB2 to initiate ErbB2/COX2/MDR1 axis. Cancer medicine (2023)